PWM
DGX icon

Parkworth Wealth Management’s Quest Diagnostics DGX Stock Holding History

Parkworth Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.44K Buy
8
+5
+167% +$868 ﹤0.01% 328
2025
Q1 		$508 Hold
3
– – ﹤0.01% 414
2024
Q4 		$453 Buy
+3
New +$467 ﹤0.01% 464

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Parkworth Wealth Management's DGX Position: Q2 2025 in Review

Parkworth Wealth Management increased its Quest Diagnostics (DGX) stake by 167% in Q2 2025, buying an estimated $868 and bringing the position to 8 shares worth $1.44K. The position accounts for ﹤0.01% of the portfolio, ranked #328.

Parkworth Wealth Management first reported a position in DGX in Q4 2024 and has held it in 3 quarters since. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Parkworth Wealth Management held 8 shares of Quest Diagnostics worth $1.44K as of Q2 2025.
  • Parkworth Wealth Management bought 5 Quest Diagnostics shares in Q2 2025, an estimated $868.
  • Quest Diagnostics made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #328 holding.
  • Parkworth Wealth Management first reported a position in Quest Diagnostics in Q4 2024 and has held it in 3 quarters since.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.